Clinical Trial Update: Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring the interventional effects of CLCF1 on Postmenopausal Osteoporosis within the context of Kidney Yin Deficiency syndrome …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• CLCF1

Snippet

Sponsor: Fujian Academy of Traditional Chinese Medicine | Conditions: Postmenopausal Osteoporosis | Phase 2 | Status: UNKNOWN